Efficacy and Safety of Certolizumab Pegol Over Four Years in Psoriatic Arthritis Patients with and without Concomitant use of DMARDS

Document Type

Abstract

Publication Date

4-2018

DOI

10.1093/rheumatology/key075.386

Journal Title

Rheumatology

Department

Dermatology

This document is currently not available here.

Share

COinS